Analysis of BCR-ABL Levels As a Predictor of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in Chronic Myeloid Leucemia (CML) in the Era of Tyrosine Kinase Inhibitors (ITQ)